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Prior studies on older adults’ risk taking have paid little attention to the healthcare 
domain. The current study examined age-related differences in medication risk taking. 
Participants were 36 English speaking younger adults (55.6% females) between the ages 
of 19 and 26 (M = 20.94, SD = 1.55), and 35 English speaking older adults (60.0% females) 
between the ages of 67 and 80 (M = 72.34, SD = 3.09). We asked them to choose between 
hypothetical medications that differed in probabilities and outcomes of treatment success. 
To investigate the effects of risk-disadvantageous versus risk-neutral versus risk-
advantageous situations, participants chose between a risky option and a sure option that 
had a higher expected value (risk-disadvantageous), between a risky option and a sure 
option that had equal expected values (risk-neutral), and between a risky option and a sure 
option that had a lower expected value (risk-advantageous). Overall, older adults were 
more risk averse. Older adults also showed a smaller increase in risk-taking tendency 
across risk-disadvantageous, risk-neutral, and risk-advantageous situations compared to 
younger adults, consistent with the idea that younger adults are more likely to use verbatim 
processing than older adults in making decisions (Peters et al., 2007; Reyna & Brainerd, 
2011). Further examination of individual participant’s medication risky choices revealed 
that younger and older adults could be essentially classified into three groups: younger 
adults who were sensitive to expected value differences between options, older adults who 
took fewer risks than did younger adults but were sensitive to expected value differences, 
and older adults who were extremely risk averse and exhibited no sensitivity to expected 
value differences (54.29% of the older adult sample). Post-hoc exploratory analyses found 
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that a variety of individual difference measures (i.e., education, perceived health, 
numeracy, health literacy, global cognitive ability, perceived severity of sickness) did not 
differentiate sensitive and insensitive older adults. This could indicate that other variables 
should be considered as an explanation for the large inter-individual variability in 
sensitivity among older adults. These findings emphasize the importance of designing 
decision aids to encourage older adults to take more (fewer) risks when risk taking is more 
(less) beneficial, and point to the need for improving the communication of outcome and 




When choosing between options in healthcare, the degree of risk involved is an important 
consideration that younger and older individuals must make. For example, they have to choose 
between painkillers that have different probabilities and magnitudes of treatment effectiveness. 
Older adults are more likely to have multiple chronic conditions, and thus they may need to make 
more choices. A National Health Interview Survey in 2012 showed that 86% of US older adults 
aged 65 or older have at least one chronic condition, and 61% have at least two chronic conditions, 
compared to 27% and 7%, respectively, of US adults aged 18 to 44 (Ward, Schiller, & Goodman, 
2014). Insofar as older patients face medical decisions that involve risks, it is important to 
investigate how they make these decisions, and whether the decision process differs as a function 
of age. 
1.1 Age-Related Differences in Risk Perception 
Because older adults are likely to suffer from multiple illnesses that require them to choose 
between treatment options with varying probabilities of success, there is a need to study age-related 
differences in risk perception and risk taking. Age-related differences in risk perception have been 
noted. For example, when risk perception was evaluated based on participants’ estimation of the 
risks of drug adverse events, older adults underestimated more frequently than did middle-aged or 
younger adults (Peters, Hart, Tusler, & Fraenkel, 2014). Furthermore, when a numeric format of 
information was provided, less numerate older adults underestimated risks more frequently than 
did other groups. However, for those who underestimated risks, risk perception was unrelated to 
willingness to take the drug, underlining the importance of examining risk taking directly. It is 
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necessary for research looking at medication risky decision making to investigate risk taking and 
not solely risk perception. 
1.2 Age-Related Differences in Risk Taking 
1.2.1 Risk-neutral decisions 
Most studies on aging and risk taking asked participants to make risk-neutral choices, 
which involve a risky option and a sure option that have equal expected values. The expected value 
of an option is calculated by multiplying outcomes by their respective probabilities, and taking the 
sum of the products (Bernoulli, 1954). A higher expected value represents a higher average value 
in the long run assuming the same option is chosen repeatedly. 
A recent meta-analysis of these studies found that older adults were more risk averse than 
younger adults in making positively framed decisions (Best & Charness, 2015). Positively framed 
decisions refer to choices in which wordings such as “keep” and “save” are used to highlight the 
positive aspects and desirable outcomes of the scenarios. This finding can be explained by fuzzy-
trace theory and the goal orientation framework. 
Fuzzy-trace theory postulates that people simultaneously store and access two types of 
representations (Reyna & Brainerd, 2011; Reyna, Nelson, Han, & Pignone, 2015). A verbatim 
representation reflects the precise information. In contrast, a gist representation captures the 
subjective interpretation of information based on emotion, experience, level of development, and 
is vague and qualitative. In the context of the Asian disease problem (Tversky & Kahneman, 1981), 
a gist representation of a sure option of “200 people will be saved” would be “some people will be 
saved” whereas a gist representation of a risky option of “a one-third probability that 600 people 
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will be saved, and a two-thirds probability that no people will be saved” would be “some 
probability that some people will be saved, and some probability that no people will be saved.” 
Hence, fuzzy-trace theory suggests that people would choose the sure option when they represent 
the positively framed situation at the gist level. Older adults are more likely than younger adults 
to rely on gist processing because they may have learned that it is a more effective means of making 
decisions (Peters, Hess, Västfjäll, & Auman, 2007). In addition, gist processing is relatively well 
preserved with normal aging although verbatim processing declines as people age (Reyna & 
Brainerd, 2011). Because older adults’ decisions are more gist-based, they are more likely to 
choose the sure option in the positive frame. 
Goal orientation is another approach that can account for the age-related differences in risk 
taking. Younger adults are likely to be growth-oriented whereas older adults may be more oriented 
towards maintenance and loss prevention (Ebner, Freund, & Baltes, 2006). When people focus on 
preventing loss, they are less likely to take risks in the positive frame. 
Although Best and Charness’ (2015) meta-analytic finding on age differences in positively 
framed choices was consistent with the prediction of fuzzy-trace theory, younger adults’ higher 
risk-taking tendency in making negatively framed choices in large-amount mortality scenarios was 
not consistent with the theory. In terms of the negative frame, a gist representation of a sure option 
of “400 people will die” would be “some people will die” whereas a gist representation of a risky 
option of “a one-third probability that nobody will die, and a two-thirds probability that 600 people 
will die” would be “some probability that nobody will die, and some probability that some people 
will die.” Hence, fuzzy-trace theory suggests that people would choose the risky option when they 
represent the negatively framed situation at the gist level. As previously discussed, older adults 
tend to show greater reliance on gist processing in making decisions compared to younger adults. 
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This leads to the expectation that older adults would be more risk taking in the negative frame. 
While no age differences were found in overall risk taking, younger adults were more likely to 
take risks in negatively framed large-amount mortality scenarios, which was not predicted by 
fuzzy-trace theory and thus demands further exploration. 
In addition to the moderating effect of amount and scenario in the negative frame, the meta-
analysis revealed an age by amount by scenario interaction in the positive frame (Best & Charness, 
2015). That is, the age effect was found in small-amount financial and large-amount mortality 
scenarios, but not in large-amount financial and small-amount mortality scenarios.  Younger and 
older adults’ levels of risk taking depend on the scenario. Owing to the heavy focus on financial 
risk seeking scenarios and the Asian disease problem in the aging literature, past findings on age-
related differences in risk taking may not generalize to medication decision making for several 
reasons. 
First, older adults are likely to have more experience in making medication decisions than 
younger adults. Their increased experience might lead them to use more affective/experiential 
processing. For instance, older adults may use more personal information (e.g., one’s own 
experience) versus the information provided in the task (e.g., probabilities) when choosing 
between medications (Hess, 2015). This might influence older adults’ medication risk preferences. 
Second, older adults, relative to younger adults, may find medication decisions more 
relevant to them. According to the selective engagement framework (Hess, 2014), task relevance 
may influence people’s use of affective/experiential versus deliberative processing. When older 
adults find a task personally meaningful, they may engage more cognitive resources, resulting in 
smaller age differences in risk taking. 
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Third, physical functioning and health decline as people age, which might change older 
adults’ sensitivity to medication outcomes (e.g., heightening their sensitivity to losses; Depping & 
Freund, 2011). Health status was associated with subjective perception of life-prolonging 
treatment outcomes (Winter & Parker, 2007). Therefore, younger and older adults might translate 
a specific medication outcome into different subjective values, which in turn affects their 
medication risk preferences. It is unknown whether risk-taking tendencies of older and younger 
adults in the medical domain would be similar to the patterns obtained in other domains. 
We have preliminary data that suggest the patterns may, in fact, differ for medication 
decisions (Chong, Bixter, & Rogers, in press). We asked 18 younger and 18 older adults to choose 
between medications that differed in probabilities and outcomes of treatment success. Contrary to 
the idea that older adults may show greater risk aversion in the positive frame, they showed a trend 
to be more risk taking than younger adults when expected values of the options were equal. 
1.2.2 Risk-advantageous and risk-disadvantageous decisions 
Studies have also explored younger and older adults’ risk taking tendencies in situations 
where risk seeking is advantageous or disadvantageous. From an economic perspective, an option 
with a higher expected value is better than an option with a lower expected value. This is also 
referred to as the expected value strategy. As predicted, Albert and Duffy (2012) found that older 
adults were less likely to take risks than younger adults. Moreover, when choosing between a sure 
option with a lower expected value and a risky option with a higher expected value, older adults 
were more risk averse than younger adults (as indicated by the graph, but no analysis was reported 
for these specific data). Analyzing trials on which the expected value of the risky option was more 
favorable than that of the sure option, older adults were shown to be more risk averse than people 
 6 
of age 5 to 64 (Weller, Levin, & Denburg, 2011). On trials that had a less favorable risky option 
than the sure option, older adults showed a marginally significant trend to be more risk taking than 
other age groups (Weller et al., 2011). Thus, older adults were less risk taking than younger adults 
when risk taking was beneficial, and they tended to be more risk taking than younger adults when 
risk aversion was beneficial. 
Based on Peters et al. (2007), and Reyna and Brainerd (2011), older adults have an 
increased tendency to use gist processing relative to younger adults. Thus, they may be less 
sensitive to the expected values of the sure and risky options and more likely to stick to their 
preferred options on risk-neutral trials than younger adults. Comparing the two age groups’ choices 
on different types of trials, our study showed that younger adults were significantly more risk 
taking on risk-advantageous trials than on risk-neutral trials, but older adults did not take 
significantly more risks when risk taking was favoured (Chong et al., in press). The older adults 
were less responsive to the expected values of options, which could be attributed to age-related 
differences in sensitivity to probabilities and/or outcomes. 
1.3 Overview of Study 
Although older adults often have multiple medical conditions and need to make health care 
choices involving risks, past research has not assessed age-related differences in risk taking for 
medication decision tasks. Younger and older adults may show different patterns of risk 
preferences in the medical domain because of differences in decision experience, personal 
relevance of the task, and health status. The goal of the current study was to study age differences 
in medication risk taking when risk taking was advantageous, neutral, or disadvantageous. 
Younger and older adults were asked to make choices between medications that involved varying 
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probabilities and outcomes of treatment success. On risk-neutral trials, they chose between options 
that were equally favorable. On risk-advantageous trials, they chose between options that favored 
risk taking. On risk-disadvantageous trials, they chose between options that favored risk aversion. 
There were two hypotheses as manipulation checks, and a hypothesis related to age 
differences. The first hypothesis was that both younger and older adults would be more risk taking 
on risk-advantageous trials than on risk-neutral trials. The second hypothesis was that both 
younger and older adults would be more risk taking on risk-neutral trials than on risk-
disadvantageous trials. Given that gist processing is relatively preserved while verbatim processing 
declines with aging (Reyna & Brainerd, 2011), older adults may be less responsive to the precise 
probability and outcome information. The third hypothesis was that there would be an age by trial 
type interaction such that older adults, compared to younger adults, show a smaller increase in risk 
taking tendency in response to risk-advantageous trials and a smaller decrease in risk taking 




Participants were 36 English speaking younger adults (55.6% females) between the ages 
of 19 and 26 (M = 20.94, SD = 1.55), and 35 English speaking older adults (60.0% females) 
between the ages of 67 and 80 (M = 72.34, SD = 3.09) after exclusion of one older adult (the reason 
for exclusion is explained in the results section). Younger adults were recruited through the 
Georgia Tech online SONA system. Older adults were recruited through the Human Factors and 
Aging Laboratory Participant Registry. 
All participants had at least 20/50 visual acuity for near vision (corrected or uncorrected) 
to ensure that they could see the stimuli. The majority of older adults were highly educated, with 
89% reporting having some college or higher. Table 1 shows the means and standard deviations 
for self-reported health, number of prescriptive medications, number of over-the-counter 
medications, number of health conditions, numeracy (Lipkus, Samsa, & Rimer, 2001), health 
literacy (Baker, Williams, Parker, Gazmararian, & Nurss, 1999), and the Montreal Cognitive 
Assessment (MoCA; Nasreddine et al. 2005) within each age group. 
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Table 1: Younger and older adults’ scores on health and cognitive measures. 
 Younger Adults Older Adults t-value 
 M SD M SD 
Self-reported general healtha 4.03 .65 3.51 .70 3.19** 
Prescriptive medicationsb .31 .71 3.40 3.22 -5.56*** 
Over-the-counter medicationsc .47 1.72 3.06 2.43 -5.17*** 
Health conditionsd .53 .88 3.29 2.20 -6.89*** 
Numeracye 9.92 1.20 7.69 2.49 4.78*** 
Health literacyf 34.44 2.06 30.91 6.37 3.12** 
MoCAg 28.44 1.30 25.54 2.37 6.38*** 
aSelf-reported health (1=poor, 5=excellent); bPrescriptive medications (the number of prescriptive 
medications taken each day); cOver-the-counter medications (the number of over-the-counter 
medications/supplements taken each day); dHealth conditions (the number of health conditions); 
eNumeracy (the score out of 11 on the numeracy scale); fHealth literacy (the score out of 36 on the 
health literacy measure); gMoCA (the score out of 30 on MoCA); **p<.01, ***p<.001. 
2.2 Materials 
Every trial of the decision task consisted of a choice between two hypothetical medications 
which had different treatment outcomes and likelihood of success. The sure option had a 100% 
chance of some treatment success whereas the risky option had a variable outcome of treatment 
success. Participants were instructed to choose one of the medications for themselves. 
There were four trial types: risk-neutral trials, risk-advantageous trials, risk-
disadvantageous trials, and catch trials. On risk-neutral trials, the medications had equivalent 
expected values. On risk-advantageous trials, the medication with a sure outcome had a lower 
expected value than the medication with a variable outcome. On risk-disadvantageous trials, the 
medication with a sure outcome had a higher expected value than the medication with a variable 
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outcome. (See Figure 1 for an example of each of the three trial types. For complete instructions, 
see Appendix A. For the risk magnitudes and the number of days of recovery on all trials, see 
Appendix B.) 
Four catch trials were included to ensure that participants understood the task, and made 
choices according to information provided on each trial rather than randomly. The medication that 
has 100% probability of leading to a fewer number of days towards full recovery, that is, the option 
that always leads to a better health outcome, was considered as the “rational” option. (For the four 
catch trials, see Appendix C.) 
Participants completed 30 risk-neutral trials, 30 risk-advantageous trials, 30 risk-
disadvantageous trials, and 4 catch trials. 
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Figure 1 - Examples of different trial types 
We considered two ways of describing the treatment outcomes: “symptoms’ and “days it 
takes to fully recover from sickness.” We chose “days it takes to fully recover from sickness” 
because “symptoms” could lead to more variable interpretations than “days it takes to fully recover 
from sickness.” We decided to provide a specific illness (i.e., bacterial infection) to participants 
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because the level of risk taking would likely depend on the decision context and we aimed to 
control for the variability in the decision context. We asked participants to rate how severe they 
perceived the sickness to be and to provide the specific illness that they had in mind after 
completing the decision task. The percentage of time that participants chose the risky option 
indicated their level of risk taking. 
2.3 Design 
Age was a grouping variable. Trial type was a within-subjects independent variable. Level 
of risk taking was the dependent variable. Other descriptive variables were demographics and 
health, health literacy, numeracy, near and far vision, and global cognitive function. 
2.4 Measures 
2.4.1 Demographics and Health 
The demographic and health questionnaire, adapted from materials developed by the 
Center for Research and Education on Aging and Technology Enhancement (Czaja et al., 2006), 
was used to collect background information of participants. The demographic questions asked 
participants to indicate their gender, age, race, English-speaking background, socioeconomic 
status, and marital status. The health questions concerned participants’ subjective and objective 
health status, as well as the number of medications they were taking at the time of the study. 
2.4.2 Post-Task Self-Report Items 
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Participants answered a question about their perceived severity of the sickness on a scale 
from one (not severe) to seven (severe), and a question about the specific illnesses that they were 
thinking about when they completed the medication decision task. (See Appendix D.) 
2.4.3 Health Literacy 
The short version of the Test of Functional Health Literacy in Adults (TOFHLA) was used 
to measure participants' ability to read and understand health-related materials (Baker et al., 1999). 
The S-TOFHLA consists of four Numeracy items and two prose passages. We only administered 
the reading comprehension portion. The Cronbach's alpha was 0.91 for the 36 items in the two 
prose passages in our sample. 
2.4.4 Numeracy 
The numeracy scale from Lipkus et al. (2001) was used to assess participants’ numeracy 
skills. It consists of three general numeracy items and eight expanded health numeracy items. 
Cronbach’s alpha was 0.75 in our sample. 
2.4.5 Ability Tests 
The Snellen visual acuity charts were used to assess participants’ near vision and far vision. 
The Montreal Cognitive Assessment (Nasreddine et al. 2005) was used to assess participants’ 
global cognitive function. It is a 30-point screening test designed to detect mild cognitive 
impairment (http://www.mocatest.org/). It measures aspects of attention, orientation, language, 
verbal memory, visuospatial, and executive function. A score that falls between 26 and 30 is 
considered normal. The time required to administer the test was approximately 10 minutes. 
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Participants completed the decision trials, self-report items, health literacy, and numeracy 
questions on a computer. They completed the MoCA using paper and pencil. 
2.5 Procedure 
Before the experiment, participants received a consent form explaining the research study. 
They consented to participate in the research study by signing the form. Then, they completed a 
questionnaire regarding demographics and health, and the ability tests. After that, participants were 
given both oral and written instructions about the decision task. Participants made medication 
decisions involving risks individually. To minimize any order effects, all decision trials were 
randomized for each participant. After all decision trials were completed, participants filled out 
the self-report items, followed by other questionnaires listed above. Finally, they were debriefed. 
It took younger adults at most one hour and older adults at most one and a half hours to 
complete the entire experiment. 
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3.1 Catch Trial Analysis 
I considered participants’ performance on the four catch trials, and only included 
participants who chose the “rational” option on three or more trials. One older participant was 
excluded because of catch trial performance, resulting in 36 younger and 35 older participants for 
data analyses. 
3.2 Medication Risk Taking (All Participants) 
The dependent variable, the level of risk taking, was a proportion based on binomial 
outcomes (i.e., choosing the risky option vs. not choosing the risky option). The errors were non-
normally distributed. Therefore, arcsine transformation was done on the proportion of risky 
options chosen on risk-disadvantageous, risk-neutral, and risk-advantageous trials. 
Then, a mixed-design ANOVA was conducted with age as the between-subjects variable, 
and trial type as the within-subjects variable on the transformed level of medication risk taking for 
all participants. As expected, the effect of trial type was significant, F(1.43, 98.34) = 117.48, p < 
.001, ω2 = .251. There was a significant linear trend, F(1, 69) = 143.73, p < .001, indicating that 
the increase in risk taking from risk-disadvantageous trials (M = .67, SD = .49) to risk-neutral trials 
(M = .99, SD = .67) to risk-advantageous trials (M = 1.33, SD = .85) was proportionate. Overall, 
older adults (M = .63, SD = .66) were significantly less risk taking than younger adults (M = 1.35, 
SD = .62), F(1, 69) = 31.89, p < .001, ω2 = .303. However, there was an age by trial type interaction 
such that the effect of trial type depended on the age group, F(1.43, 98.34) = 20.19, p < .001, ω2 = 
.049. The age group x trial type linear partial interaction was significant, F(1, 69) = 24.58, p < 
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.001. The linear change in risk taking across trial types was smaller in older adults (risk-
disadvantageous: M = .44, SD = .47; risk-neutral: M = .64, SD = .64; risk-advantageous: M = .82, 
SD = .79) than in younger adults (risk-disadvantageous: M = .89, SD = .39; risk-neutral: M = 1.33, 
SD = .50; risk-advantageous: M = 1.82, SD = .57). Figure 3 shows the results. 
 
Figure 3 - Young and old adults’ level of risk taking (without the arcsine transformation) on 
risk-disadvantageous, risk-neutral, and risk-advantageous trials (error bars represent the 
standard error) 
Although the above bar chart showed the mean age trends, it obscured individual 
differences in sensitivity to the three trial types. Sensitivity was not a specific measure in the study. 
It refers to the increase in medication risk taking when the scenario changed from risk-
disadvantageous to risk-neutral to risk-advantageous. Heatmaps allow the use of color to represent 
the magnitude of risk taking for each individual. Hence, they are useful in visualizing individual 
differences in risk-taking tendency on different trial types. In Figure 4, the heatmap on the left 



























Younger adults Older adults
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shows the data for individual older adults. It is clear that older adults could be categorized as 2 
groups: a group of older adults who took about the same level of risk on all trial types and another 
group of older adults who took more risks as risk taking became more advantageous. Based on the 
strong visual evidence of inter-individual variability among older adults, a post-hoc analysis on 
the risky choices at the individual level was performed. It revealed that 54.29% of older adults and 
5.56% of younger adults showed little to no sensitivity to the different trial types (see individuals 
surrounded by the boxes in Figure 4). These insensitive older and younger adults’ levels of risk 
taking on the risk-disadvantageous, risk-neutral, and risk-advantageous trials were within an intra-
individual range of 3.33% while the levels of risk taking of the remaining sensitive participants 
had an intra-individual range of at least 13.33%. All except one of the insensitive participants were 
extremely risk averse, choosing the sure option on at least 96.67% of the trials. 
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Figure 4 - Heatmap showing individual younger and older adults’ level of risk taking (from 
light blue: extremely risk averse to dark blue: extremely risk taking) on risk-
disadvantageous, risk-neutral, and risk-advantageous trials 
3.3 Medication Risk Taking (Sensitive Participants) 
To investigate how the larger proportion of older adults who were insensitive to trial types 
might have played a role in the age by trial type interaction, I conducted the same mixed-design 
ANOVA analyses on the level of medication risk taking for the subsample of sensitive participants 
(34 younger and 16 older adults). In comparison to the analyses including all participants, the main 
effects remained significant for trial type, F(1.59, 76.33) = 202.62, p < .001, ω2 = .838, and age 
group, F(1, 48) = 6.59, p < .05, ω2 = .101. The risk-taking pattern remained the same, increasing 
across the risk-disadvantageous, risk-neutral, and risk-advantageous trials. Older adults were more 
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risk averse than younger adults. However, the interaction effect of age group by trial type was no 
longer significant, F(1.59, 76.33) = 1.84, ns, ω2 = .004. Figure 5 shows the results. 
 
Figure 5 - Young and old adults’ level of risk taking (without the arcsine transformation) in 
the subsample of sensitive participants on risk-disadvantageous, risk-neutral, and risk-
advantageous trials (error bars represent the standard error) 
In addition to the analysis on risky choices by trial type, it is valuable to break down 
sensitivity to trial types to sensitivity to expected value differences. I examined whether sensitive 
participants increased their level of risk taking with respect to the expected value difference 
between the sure and risky options, and whether sensitive older adults increased their level of risk 
taking in a similar way as did sensitive younger adults. Figure 6 shows that both younger and older 
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Figure 6 – Younger and older sensitive participants’ level of risk taking as a function of 
expected value difference between options (positive expected value differences mean the 
risky option had a higher expected value than the sure option, and vice versa) 
The following multilevel model was fitted to the data: 
Level 1 equation: 
Risk taking =  β0j +  β1j (Expected value differenceij)  +  rij 
Level 2 equations: 
β0j = γ01(Age_group𝑗)  +  γ00  +  𝑢0j  
β1j = γ11(Age_group𝑗)  +  γ10  + 𝑢1j  
Overall mixed model equation: 
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Risk taking =  γ01(Age_group𝑗)  + γ10(Expected value differenceij) +  γ11(Age_group𝑗)
× (Expected value differenceij) +  γ00  +  𝑢0j   
+  𝑢1j (Expected value differenceij)  +  rij 
γ01, γ10, γ11, and γ00 captured the fixed effects of age group, within-participant expected value 
difference, interaction between age group and expected value difference, and the intercept, 
respectively. u0j, u1j, and rij captured the random effects of the intercept, slope, and error, 
respectively. Table 2 presents the estimates obtained from the model. 
Table 2: Parameter estimates and 95% confidence intervals (CIs) obtained by fitting the 
multilevel model to sensitive participants’ data, predicting medication risk taking. 
Parameter Estimate 95% CI 
Fixed Effects   
    Intercept 1.396*** [1.246, 1.546] 
    Expected Value Difference .187*** [.163, .211] 
    Age Group -.302* [-.567, -.036] 
    Expected Value Difference x Age Group -.022 [-.065, .020] 
Variance/ Covariance Parameters   
    Residual .710*** [.646, .781] 
    Intercept .152*** [.093, .251] 
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Table 2 continued. 
    Intercept-Slope Covariance .008 [-.001, .017] 
    Slope .002* [.001, .005] 
*p<.05, **p<.01, ***p<.001. 
The multilevel modeling results were consistent with the mixed-design ANOVA results. 
There were significant fixed effects of expected value difference and age group, but the expected 
value difference by age group interaction effect was not significant. Expected value difference 
(i.e., expected value of the risky option – expected value of the sure option) was positively 
associated with risk taking. The older age group was negatively associated with risk taking. 
3.4 Individual Characteristics of Insensitive and Sensitive Older Participants 
Additionally, I conducted separate independent samples t-tests to understand if older 
participants who were insensitive and sensitive to trial types differed on education, self-reported 
general health, numeracy, health literacy, MoCA, and post-task self-reported severity of sickness. 
Insensitive and sensitive older adults did not differ on any of these individual characteristic 
measures. Table 3 shows the t-test results.   
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t-value df p 
Education 5.64 (1.34) 5.81 (.98) -.46 32.43 .65 
General health 3.63 (.76) 3.38 (.62) 1.08 33 .29 
Numeracy 7.79 (2.44) 7.56 (2.63) .26 33 .79 
Health literacy 31.95 (5.20) 29.69 (7.52) 1.05 33 .30 
MoCA 25.84 (2.14) 25.19 (2.64) .81 33 .42 
Perceived severity of 
sickness 




Findings from the present study provide insights into younger and older adults’ risky 
decision making for medications. Confirming our expectation, relative to situations wherein risk 
taking and risk aversion were equally favorable, younger and older adults took more risks when 
risk taking was beneficial, and they took fewer risks when risk aversion was beneficial. Overall, 
older adults were less risk taking than younger adults. However, the effect of trial type differed 
between the two age groups such that the linear change in risk taking among older adults was 
smaller than that among younger adults across risk-disadvantageous, risk-neutral, and risk-
advantageous scenarios. Focusing only on participants that demonstrated sensitivity to trial types 
older adults remained less risk taking, but the risk-taking trend on different trial types no longer 
depended on the age group. The large proportion of insensitive older adults could account for the 
age difference in increase in risk taking across situations. Further investigation at the more granular 
level of expected value differences regarding sensitive younger and older adults’ choices yielded 
consistent results. 
4.1 Theoretical Implications 
Findings from the study suggested that younger and older adults could be essentially 
classified into three groups: younger adults who were sensitive to expected value differences, older 
adults who took fewer risks than did younger adults but were sensitive to expected value 
differences, and older adults who were extremely risk averse and exhibited no sensitivity to 
expected value differences. 
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The finding that older adults could be categorized as two groups is a novel finding, 
suggesting that older individuals likely relied on different levels of gist when making the 
medication risky decisions. Older adults’ choices could be explained by fuzzy-trace theory (Reyna 
& Brainerd, 2011; Reyna et al., 2015) and goal orientation (Ebner et al., 2006), whereas insensitive 
older adults’ choices could be explained by fuzzy-trace theory (Reyna & Brainerd, 2011; Reyna 
et al., 2015) and people’s general risk aversion tendency (Tversky & Kahneman, 1986). 
According to fuzzy-trace theory, people prefer to use simpler representations as the bottom-
line meaning in discriminating between options (Reyna & Brainerd, 2011; Reyna et al., 2015). 
When categorical something-nothing contrasts are emphasized as in typical risky-choice problems, 
individuals are more likely to choose the risky option in the negative frame because they find the 
zero-loss outcome attractive (Reyna, Chick, Corbin, & Hsia, 2014). However, the risky option in 
the current study did not include a zero-loss outcome because an outcome of recovering in zero 
days is not likely to happen in everyday medical contexts. 
Sensitive older adults’ lower risk-taking tendency relative to younger adults suggests that 
the former might have used an ordinal gist representation. They might have represented the gist of 
the decision scenario as choosing between the risky option: some chance of fully recovering in a 
maximum number of days and some chance of fully recovering in a minimum number of days, 
and the sure option: fully recovering in a few/some/many days (corresponding to risk-
disadvantageous, risk-neutral, and risk-advantageous trials). When older adults have a goal to 
minimize losses (Ebner et al, 2006), they may tend to prefer the sure medication option relative to 
younger adults. Meanwhile, sensitive older adults were more risk taking in risk-advantageous 
situations than in other situations. This was likely because they were motivated to reduce the loss 
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of fully recovering in many days by choosing the risky medication option which had a potential 
outcome of fully recovering in a minimum number of days. 
Insensitive older adults who chose the medication with a sure outcome in every situation 
regardless of expected value differences likely used a categorical gist representation. To ensure 
that the risky option was sometimes less favorable, equally favorable, or more favorable, the 
precise treatment outcome and probability information was changed across trials. However, if 
older adults were not taking into account the verbatim representation of choice options in making 
the medication decisions, they would not be responding correspondingly to the risk-
disadvantageous, risk-neutral, and risk-advantageous trials. The observation of insensitive older 
adults suggests that they likely extracted the meaning of the decision scenario in a fuzzy way as 
choosing between a sure medication option and a risky medication option. Given this gist 
representation and people’s general risk aversion tendency (Tversky & Kahneman, 1986), 
insensitive older adults thus chose the sure medication option all the time to avoid uncertainty. 
The present study adds to the literature in that it investigated age differences in risk taking 
in the medical domain, which has heretofore been understudied. Despite the lack of overall age 
differences in the negative frame, the Best and Charness (2015) meta-analysis showed that the age 
effect was present in large-amount mortality scenarios, but not in other scenarios. Thus, factors 
such as amount (i.e., number of days until full recovery in the current study) and domain influence 
the presence of age-related differences in risk taking. Older adults’ greater risk aversion in the 
present study could be additional evidence that age-related differences in risk preferences are 
context dependent. People may evaluate the options differently in situations involving money, 
human lives, or treatment of illness. Age-related differences in risk taking in the medical domain 
require further exploration. 
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The current study only makes a novel contribution to the literature, it also adds support to 
previous findings. Overall, older adults were less sensitive to expected value differences than 
younger adults, consistent with the idea that older adults are more likely to use gist processing 
whereas younger adults are more likely to use verbatim processing in making decisions (Peters et 
al., 2007; Reyna & Brainerd, 2011). Additionally, both groups of older adults took fewer risks than 
did younger adults, consistent with the meta-analytic finding of age-related differences in 
negatively-framed large-amount mortality scenarios (Best & Charness, 2015). 
When only sensitive participants were considered, there was no longer an age group by 
trial type interaction effect. The significant reduction in effect size after excluding insensitive 
participants suggests that the age group by trial type interaction was mainly attributable to the large 
proportion of older adults who were not responsive to trial types and were extremely risk averse 
in all decision situations. Given the small sample size in the follow-up analyses, it is inconclusive 
whether the risk-taking trend across risk-disadvantageous, risk-neutral, and risk-advantageous 
situations is different for younger versus older age group among those showing at least some 
sensitivity. While it would be valuable to fit computational models to participants’ risky choices, 
these models require that people demonstrate at least some sensitivity to the outcome and/or 
probability information presented to them. The small sample of sensitive older adults would limit 
the insights that modeling analyses could offer. Future research should investigate whether 
sensitive younger and older adults adjust to the decision scenarios to differential extents. 
The finding that none of the potential variables predicted older adults’ sensitivity to trial 
types could be due to the small sample size of older adults. It could also indicate that other variables 
should be considered as the explanation. Individual differences in medication decision-making 
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experience and decision strategies might be able to account for the variability in older adults’ risky 
choices. Future work should explore these possibilities. 
Although experience in making medication decisions was not measured directly, there was 
likely a large within-group variation in medication decision-making experience among the older 
adults given the large within-group variation in the number of medications each participant took. 
A study investigating risky decision making among intelligence agents, college students, and post-
college adults showed that the tendency to base decisions on the gist representation (meaning) 
increased with experience in the domain (Reyna et al., 2014). Therefore, older adults who are more 
experienced in choosing between medications may tend to rely on the gist of the choice options in 
making the decisions whereas those who are less experienced may be more likely to rely on the 
verbatim representation. A lack of responsiveness to trial types in the present study could reflect 
gist-based decision making. Future research could test the association between domain-specific 
decision-making experience and sensitivity to risk-disadvantageous, risk-neutral, and risk-
advantageous conditions. 
Individual differences in decision strategies could be another factor that contributed to 
older adults’ sensitivity to trial types (or lack thereof). Some older adults might use emotion-
focused strategies to maximize positive emotion because of a motivational shift in their goals or 
age-related declines in cognitive resources (Carstensen, Isaacowitz, & Charles, 1999; Labouvie-
Vief, 2003; Labouvie-Vief & Medler, 2002; Löckenhoff & Carstensen, 2007); however, others 
might use information-focused strategies. When people use emotion-focused strategies and place 
a great emphasis on valence, they might regard other information such as probabilities as irrelevant 
in decision making (Rivers, Reyna, & Mills, 2008). The selection of emotion-focused strategies 
among some older adults in our sample might have led them to choose the sure option regardless 
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of detailed information presented in the task. Additional research efforts are needed to deepen our 
understanding of younger and older adults’ strategy use and its relation to risk preferences across 
risk-disadvantageous, risk-neutral, and risk-advantageous situations. 
4.2 Practical Implications 
Examining age-related differences in medication risk seeking enabled us to understand 
more about younger and older adults’ risk preferences and hence provided us with the knowledge 
to devise appropriate decision aids for each group. This is especially important as policies in the 
US increasingly emphasize patient-centered care, which means that patients now have a greater 
responsibility for making their own health care decisions (Mitzner, McBride, Barg-Walkow, & 
Rogers, 2013). The present study offers evidence that a significant proportion of older adults tend 
to show less sensitivity to objective probability and outcome information. Thus, risk 
communication professionals may want to train older adults to attend more to these kinds of 
information, or change the presentation of materials to highlight the meaning of these aspects to 
older adults. Future research should examine these possibilities and contribute to the development 
of tools to facilitate younger and older adults’ risky decision making in the medical domain. 
4.3 Conclusion 
Maintaining health and recovering from sickness require individuals to choose between 
medications. The current study investigated younger and older adults’ risky decision making with 
the use of a medication choice task. Older adults were less risk taking than younger adults, and 
older adults showed a smaller increase in their risk-taking tendency across situations than did 
younger adults. This interaction was explained by the large number of insensitive older 
participants. More than half of older adults were insensitive in that they were extremely risk averse 
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in all situations including situations that favor risk taking. Although some older adults appeared to 
make their medication risky decisions according to exact probabilities and outcomes, a substantial 
proportion of older adults in our sample seemed to have a great preference for certainty and make 
gist-based medication risky choices. In practice, medical professionals should focus on explaining 
the meaning of different medication options to older adults who rely on gist processing, rather than 
merely present numerical information to these older adults. As the next steps, researchers could 
conduct a study on a larger sample of younger and older adults to better understand whether older 
adults are less responsive to risk-disadvantageous, risk-neutral, and risk-advantageous situations 
than younger adults, and the individual characteristics that could predict the sensitivity to expected 
value difference between options among older adults.  
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APPENDIX A. INSTRUCTIONS FOR PARTICIPANTS 
In the following task you will be making medication decisions. In each situation there will be a choice between two 
medications with different treatment outcomes and probabilities. For example, you might see the following display 
on the computer screen: 
 
 
You have been diagnosed with a bacterial infection. Which antibiotic medication would you choose? 
Medication A 
30% chance of fully recovering in 30 days 
and 
70% chance of fully recovering in 10 days 
Medication B 
100% chance of fully recovering in 16 days 
 
 
This means that you have a choice between one dose of medication A, with a 30% chance of fully recovering in 30 
days and a 70% chance of fully recovering in 10 days, and one dose of medication B, with a 100% chance of fully 
recovering in 16 days. Choices are made by pressing the ‘z’ or ‘/’ key on the computer keyboard.  If you would 
choose the medication on the left side of the screen, press the ‘z’ key. If you would choose the medication on the 
right side of the screen, press the ‘/’ key.  
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Another example of what you might see on the computer screen is the following display: 
 
 
You have been diagnosed with a bacterial infection. Which antibiotic medication would you choose? 
Medication A 
100% chance of fully recovering in 11 days 
Medication B 
75% chance of fully recovering in 15 days 
and 
25% chance of fully recovering in 5 days 
 
 
This means that you have a choice between one dose of medication A, with a 100% chance of fully recovering in 11 
days, and one dose of medication B, with a 75% chance of fully recovering in 15 days and a 25% chance of fully 
recovering in 5 days. Choices are made by pressing the ‘z’ or ‘/’ key on the computer keyboard.  If you would choose 
the medication on the left side of the screen, press the ‘z’ key. If you would choose the medication on the right side 
of the screen, press the ‘/’ key. 
Finally, although these medications are hypothetical, please imagine what your choice would be if they were real.  
We will do several practice items. Do you have any questions? 
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APPENDIX B. RISK MAGNITUDES AND NUMBER OF DAYS OF RECOVERY ON ALL TRIALS 
 Risk-neutral EV diff Risk-disadvantageous EV diff Risk-advantageous EV diff 
Risky 10% 30 90% 10 
0 
10% 30 90% 10 
1 
10% 30 90% 10 
-1 
Sure 12 11 13 
Risky 20% 30 80% 10 
0 
20% 30 80% 10 
3 
20% 30 80% 10 
-3 
Sure 14 11 17 
Risky 40% 30 60% 10 
0 
40% 30 60% 10 
5 
40% 30 60% 10 
-5 
Sure 18 13 23 
Risky 60% 30 40% 10 
0 
60% 30 40% 10 
2 
60% 30 40% 10 
-2 
Sure 22 20 24 
Risky 80% 30 20% 10 
0 
80% 30 20% 10 
3 
80% 30 20% 10 
-3 
Sure 26 23 29 
Risky 90% 30 10% 10 
0 
90% 30 10% 10 
1.5 
90% 30 10% 10 
-1.5 
Sure 28 26.5 29.5 
Risky 10% 25 90% 5 
0 
10% 25 90% 5 
1 
10% 25 90% 5 
-1 
Sure 7 6 8 
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Risky 20% 25 80% 5 
0 
20% 25 80% 5 
3 
20% 25 80% 5 
-3 
Sure 9 6 12 
Risky 40% 25 60% 5 
0 
40% 25 60% 5 
3 
40% 25 60% 5 
-3 
Sure 13 10 16 
Risky 60% 25 40% 5 
0 
60% 25 40% 5 
4 
60% 25 40% 5 
-4 
Sure 17 13 21 
Risky 80% 25 20% 5 
0 
80% 25 20% 5 
3 
80% 25 20% 5 
-3 
Sure 21 18 24 
Risky 90% 25 10% 5 
0 
90% 25 10% 5 
1 
90% 25 10% 5 
-1 
Sure 23 22 24 
Risky 10% 20 90% 10 
0 
10% 20 90% 10 
0.5 
10% 20 90% 10 
-0.5 
Sure 11 10.5 11.5 
Risky 20% 20 80% 10 
0 
20% 20 80% 10 
1.5 
20% 20 80% 10 
-1.5 
Sure 12 10.5 13.5 
Risky 40% 20 60% 10 
0 
40% 20 60% 10 
3 
40% 20 60% 10 
-3 
Sure 14 11 17 
Risky 60% 20 40% 10 0 60% 20 40% 10 3 60% 20 40% 10 -3 
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Sure 16 13 19 
Risky 80% 20 20% 10 
0 
80% 20 20% 10 
1.5 
80% 20 20% 10 
-1.5 
Sure 18 16.5 19.5 
Risky 90% 20 10% 10 
0 
90% 20 10% 10 
0.5 
90% 20 10% 10 
-0.5 
Sure 19 18.5 19.5 
Risky 10% 15 90% 5 
0 
10% 15 90% 5 
0.5 
10% 15 90% 5 
-0.5 
Sure 6 5.5 6.5 
Risky 20% 15 80% 5 
0 
20% 15 80% 5 
1 
20% 15 80% 5 
-1 
Sure 7 6 8 
Risky 40% 15 60% 5 
0 
40% 15 60% 5 
3 
40% 15 60% 5 
-3 
Sure 9 6 12 
Risky 60% 15 40% 5 
0 
60% 15 40% 5 
3 
60% 15 40% 5 
-3 
Sure 11 8 14 
Risky 80% 15 20% 5 
0 
80% 15 20% 5 
1 
80% 15 20% 5 
-1 
Sure 13 12 14 
Risky 90% 15 10% 5 
0 
90% 15 10% 5 
0.5 
90% 15 10% 5 
-0.5 
Sure 14 13.5 14.5 
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Risky 10% 30 90% 5 
0 
10% 30 90% 5 
1.5 
10% 30 90% 5 
-1.5 
Sure 7.5 6 9 
Risky 20% 30 80% 5 
0 
20% 30 80% 5 
4 
20% 30 80% 5 
-4 
Sure 10 6 14 
Risky 40% 30 60% 5 
0 
40% 30 60% 5 
7 
40% 30 60% 5 
-7 
Sure 15 8 22 
Risky 60% 30 40% 5 
0 
60% 30 40% 5 
6 
60% 30 40% 5 
-6 
Sure 20 14 26 
Risky 80% 30 20% 5 
0 
80% 30 20% 5 
4 
80% 30 20% 5 
-4 
Sure 25 21 29 
Risky 90% 30 10% 5 
0 
90% 30 10% 5 
1.5 
90% 30 10% 5 
-1.5 




APPENDIX C. CATCH TRIALS 
You have been diagnosed with a bacterial infection. Which antibiotic medication would you choose? 
Medication A 
A 60% chance of fully recovering in 30 days 
and 
a 40% chance of fully recovering in 20 days 
Medication B 
A 100% chance of fully recovering in 15 days 
 
You have been diagnosed with a bacterial infection. Which antibiotic medication would you choose? 
Medication A 
A 20% chance of fully recovering in 25 days 
and 
a 80% chance of fully recovering in 10 days 
Medication B 




You have been diagnosed with a bacterial infection. Which antibiotic medication would you choose? 
Medication A 
A 40% chance of fully recovering in 20 days 
and 
a 60% chance of fully recovering in 5 days 
Medication B 
A 100% chance of fully recovering in 3 days 
 
You have been diagnosed with a bacterial infection. Which antibiotic medication would you choose? 
Medication A 
A 90% chance of fully recovering in 30 days 
and 
a 10% chance of fully recovering in 15 days 
Medication B 





APPENDIX D. POST-TASK SELF-REPORT ITEMS 
1. In this study, when you were making choices about medications, how severe did you think the sickness was? 
(from 1 not severe to 7 severe) 
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